Sofinnova Investments, Inc. Intra Cellular Therapies, Inc. Transaction History

Sofinnova Investments, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $2.2 Million - $3.53 Million	-56,915 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $6 Million - $9.11 Million	-170,504 Reduced 74.97%	56,915 $2.98 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $2.46 Million - $3.64 Million	-85,740 Reduced 27.38%	227,419 $8.48 Million
Q2 2021 Aug 16, 2021	SELL	$29.3 - $44.5 $10 Million - $15.2 Million	-341,842 Reduced 52.19%	313,159 $12.8 Million
Q1 2021 May 14, 2021	SELL	$30.8 - $39.51 $5.95 Million - $7.63 Million	-193,161 Reduced 22.77%	655,001 $22.2 Million
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $8.04 Million - $11.1 Million	344,607 Added 68.43%	848,162 $27 Million
Q3 2020 Nov 13, 2020	BUY	$17.61 - $31.86 $4.61 Million - $8.34 Million	261,647 Added 108.16%	503,555 $12.9 Million
Q2 2020 Aug 13, 2020	BUY	$14.35 - $26.64 $2.73 Million - $5.06 Million	189,903 Added 365.16%	241,908 $6.21 Million
Q1 2020 May 13, 2020	BUY	$12.31 - $33.12 $640,181 - $1.72 Million	52,005 New	52,005 $800,000
Q3 2019 Nov 14, 2019	SELL	$7.47 - $14.03 $940,883 - $1.77 Million	-125,955 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$10.65 - $14.29 $1.34 Million - $1.8 Million	125,955 New	125,955 $1.64 Million

379

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.96B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.